Literature DB >> 22964060

A campaign for information and diagnosis of atrial fibrillation: "pulse week".

Marcelo Sanmartín1, Francisco Fraguela Fraga, Angel Martín-Santos, Pilar Moix Blázquez, Alba García-Ruiz, María Vázquez-Caamaño, Manuel Vilar.   

Abstract

INTRODUCTION AND
OBJECTIVES: Atrial fibrillation occurs in 5%-15% of elderly patients and causes one-fourth to one-fifth of all cerebrovascular events. These patients are frequently asymptomatic. We conducted a public campaign aiming to evaluate the effectiveness of a program for information on and diagnosis of atrial fibrillation in individuals aged 65 years old or more from the primary care perspective.
METHODS: We sent letters containing informative materials and an invitation to attend a special nurse appointment to all individuals≥65 years old, without a previous diagnosis of atrial fibrillation or flutter. Patients were from 3 specific areas in Pontevedra province. The procedures were performed according to a specially designed program called "Pulse Week" within 5 working days. A group of trained nurses obtained a brief medical history and performed pulse palpation for 15 s and blood pressure measurement. A complete 12-lead electrocardiogram was performed if arrhythmic pulsations were detected.
RESULTS: A total of 8869 letters were sent. During the specified week, 1532 individuals were evaluated (877 women); the mean age was 72.5 (6.5) years old, 833 had hypertension (54%), 232 had diabetes (15%), 61 had previous stroke (4%) and 88 had had a myocardial infarction (6%). Electrocardiograms were performed in 187 patients. There were 17 patients with newly diagnosed atrial fibrillation.
CONCLUSIONS: A public, 5-day campaign based on pulse palpation and targeting elderly individuals had little impact on the detection of new cases of atrial fibrillation in our environment.
Copyright © 2012 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22964060     DOI: 10.1016/j.recesp.2012.05.012

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  6 in total

1.  Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.

Authors:  Femke Kaasenbrood; Monika Hollander; Steven Hm de Bruijn; Carlijn Pe Dolmans; Robert G Tieleman; Arno W Hoes; Frans H Rutten
Journal:  Br J Gen Pract       Date:  2020-05-28       Impact factor: 5.386

2.  Atrial fibrillation prevalence and predictors in patients with diabetes: a cross-sectional screening study.

Authors:  Angela Hall; Andrew Robert John Mitchell; Lisa Ashmore; Carol Holland
Journal:  Br J Cardiol       Date:  2022-03-08

3.  Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).

Authors:  Mintu P Turakhia; Aditya J Ullal; Donald D Hoang; Claire T Than; Jared D Miller; Karen J Friday; Marco V Perez; James V Freeman; Paul J Wang; Paul A Heidenreich
Journal:  Clin Cardiol       Date:  2015-04-14       Impact factor: 2.882

4.  Atrial Fibrillation Screening in Nonmetropolitan Areas Using a Telehealth Surveillance System With an Embedded Cloud-Computing Algorithm: Prospective Pilot Study.

Authors:  Juey-Jen Hwang; Yi-Lwun Ho; Ying-Hsien Chen; Chi-Sheng Hung; Ching-Chang Huang; Yu-Chien Hung
Journal:  JMIR Mhealth Uhealth       Date:  2017-09-26       Impact factor: 4.773

5.  Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study.

Authors:  Jonas Hald; Peter Bo Poulsen; Ina Qvist; Lisbeth Holm; Dorte Wedell-Wedellsborg; Lars Dybro; Lars Frost
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

6.  Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis.

Authors:  Pawel Petryszyn; Piotr Niewinski; Aleksandra Staniak; Patryk Piotrowski; Anna Well; Michal Well; Izabela Jeskowiak; Gregory Lip; Piotr Ponikowski
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.